Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Battle for the Ages

As I was watching the pompom news channel (CNBC), they went into full damage control over Thursday's massacre, and I thought to myself, "What markets or media bullet points do 'the boys' need to control today in order to avoid a weekly sell signal and ensuing panic?" In...
Streetwise Reports | June 16, 2020 |

Fresh water crisis unfolding

When planetary scientists search for life on other planets the first thing they look for is evidence of water. “There are two main questions in the search for life: With so many places to look, how can we focus in on the places most likely to harbor life? What are the unmi...
Richard (Rick) Mills | August 23, 2019 |

PhaseBio Shares Are on a Tear After Reporting Phase 2a Trial Results

The clinical-stage biopharmaceutical stock surged more than 30% Wednesday following a report that PB2452 caused immediate and sustained reversal of ticagrelor in older and elderly subjects. In a press release issued September 24, PhaseBio Pharmaceuticals Inc. (PHAS...
Streetwise Reports | September 26, 2019 |

Underowned and Underloved

Back in the Dark Ages, before cellular phones and the Internet, I was studying to complete the Ontario Securities course one afternoon when I came across the part discussing "asset allocation" and "portfolio construction." This section covered the recommended mix of bonds...
Streetwise Reports | April 14, 2020 |

2021’s Surging Investment Opportunity? E-Sports is the Answer

(Click image to play video) Despite most of our social plans being ruined in 2020, one industry that has not only remained afloat during the COVID-19 pandemic but thrived is e-sports. Gaming market analytics company New-Zoo forecasts that the industry will gener...
Stockhouse Editorial | February 18, 2021 |

When the levee breaks

In George Steinbeck’s epic novel ‘The Grapes of Wrath’, a poor family of tenant farmers and thousands of other “Oakies” hitch up their wagons to make the trek to California in search of work and a better life. A savage dr...
Richard (Rick) Mills | October 4, 2019 |

Buzz on the Bullboards: Defending Voter Rights

(Image via @porkchopchili.) There is one burning topic among Stockhouse’s Bullboards of late … the showdown for the White House. Early voting is underway in the US for what is a presidential election for the ages and as we all know, there has been ...
Stockhouse Editorial | October 21, 2020 |

Fandom Sports Set to Launch NFT Marketplace Including Gamification & Rewards

THE PLATFORM PLANS TO REWARD FAN ENGAGEMENT WITH UTILITY AND UNIQUE CUSTOM NFTS Fandom Sports Media Corporation ( CSE: FDM , Forum ) , a Vancouver-based gaming and entertainment company, is all set to launch its all-ages gamification platform that will reward fan engageme...
Chris Thompson | April 5, 2022 |

Morning Market Outlook for Feb. 7, 2024

Stephen Whiteside of TheUpTrend.com analyzes major indices, numerous sectors, semiconductors, commodities and much more in Wednesday’s Morning Market Outlook. Navigate the dynamic world of market moves effortlessly and stay ahead of the game with dai...
TheUpTrend | February 7, 2024 |

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...
Streetwise Reports | September 6, 2019 |
1 2 3 4 5 6 7 8 9 10 ...